drugset / Trial / NCT02027831

NIR Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After iv Injection of ICG

NCT02027831

Phase 2 Unknown 10 enrolled Jules Bordet Institute
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine if NIR fluorescent imaging is an effective approach to detect the margins of head and neck tumours or lymph nodes draining the tumour

Timeline

Start
2013-12
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 0.25 mg/kg Intravenous

Indications